CNBC July 23, 2024
Key Points
– Bipartisan lawmakers introduced a new bill that aims to crack down on the business practices of drug supply chain middlemen who allegedly inflate prescription medication prices in the U.S.
– The legislation aims to lower costs for patients enrolled in federal healthcare programs and ensure that community pharmacies are reimbursed fairly by so-called pharmacy benefit managers.
– It comes amid a House committee hearing featuring testimony by the three largest PBMs, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts.
Bipartisan lawmakers introduced a new bill on Tuesday that aims to crack down on the business practices of drug supply chain middlemen who are widely accused of inflating prescription medication prices and harming U.S. patients...
Today's Sponsors
Today's Sponsor